논문상세정보
' ORiginal Article : Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 기초의학
  • glypican-3
  • hepatocellular carcinoma
  • osteopontin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
768 0

0.0%

' ORiginal Article : Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma' 의 참고문헌

  • The role of Osteopontin in tumor metastasis
    Wai PY J Surg Res 121 : 228 ~ 241 - [2004]
  • The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma
    Zhang H J Cancer Res Clin Oncol 132 : 709 ~ 717 - [2006]
  • The incidence and epidemiology of hepatocellular carcinoma : a global and regional perspective
    Venook AP Oncologist 15 (Suppl 4) : 5 ~ 13 - [2010]
  • Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome
    Stravitz RT Am J Med 121 : 119 ~ 126 - [2008]
  • Simultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinoma
    Qiao SS Hepatogastroenterology 58 : 1718 ~ 1724 - [2011]
  • Simplified staging for hepatocellular carcinoma
    Vauthey JN J Clin Oncol 20 : 1527 ~ 1536 - [2002]
  • Serum alphafetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
    Trevisani F J Hepatol 34 : 570 ~ 575 - [2001]
  • Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population
    Sherman M Hepatology 22 : 432 ~ 438 - [1995]
  • Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study
    McMahon BJ Hepatology 32 (4 Pt 1) : 842 ~ 846 - [2000]
  • Role of the metastasis-promoting protein osteopontin in the tumour microenvironment
    Anborgh PH J Cell Mol Med 14 : 2037 ~ 2044 - [2010]
  • Role of osteopontin in cellular signaling and metastatic phenotype
    El-Tanani MK Front Biosci 13 : 4276 ~ 4284 - [2008]
  • Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis
    Zhang CH Int J Cancer 130 : 2685 ~ 2692 - [2012]
  • Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma
    Pan HW Cancer 98 : 119 ~ 127 - [2003]
  • Overexpression of osteopontin in hepatocellular carcinoma
    Gotoh M Pathol Int 52 : 19 ~ 24 - [2002]
  • Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling
    Urtasun R Hepatology 55 : 594 ~ 608 - [2012]
  • Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis
    Syn WK Hepatology 53 : 106 ~ 115 - [2011]
  • Osteopontin expression in normal and fibrotic liver altered liver healing in osteopontindeficient mice
    Lorena D J Hepatol 44 : 383 ~ 390 - [2006]
  • Osteopontin as a target for cancer therapy
    Johnston NI Front Biosci 13 : 4361 ~ 4372 - [2008]
  • Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
    Singal A Aliment Pharmacol Ther 30 : 37 ~ 47 - [2009]
  • Management of hepatocellular carcinoma : an update
    Bruix J Hepatology 53 : 1020 ~ 1022 - [2011]
  • Management of hepatocellular carcinoma
    Bruix J Hepatology 42 : 1208 ~ 1236 - [2005]
  • Identification of osteopontin as a novel marker for early hepatocellular carcinoma
    Shang S Hepatology 55 : 483 ~ 490 [2012]
  • Hepatocellular carcinoma
    El-Serag HB N Engl J Med 365 : 1118 ~ 1127 - [2011]
  • Glypicans: proteoglycans with a surprise
    Filmus J J Clin Invest 108 : 497 ~ 501 - [2001]
  • Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
    Capurro M Gastroenterology 125 : 89 ~ 97 - [2003]
  • Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
    Nakatsura T Biochem Biophys Res Commun 306 : 16 ~ 25 - [2003]
  • Frequent silencing of the GPC3 gene in ovarian cancer cell lines
    Lin H Cancer Res 59 : 807 ~ 810 - [1999]
  • Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma
    Murthy SS Oncogene 19 : 410 ~ 416 - [2000]
  • Elevated plasma osteopontin levels in patients with hepatocellular carcinoma
    Kim J Am J Gastroenterol 101 ( ) : 2051 ~ 2059 - [2006]
  • Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gammacarboxy prothrombin: a prospective study
    Ikoma J Hepatogastroenterology 49 : 235 ~ 238 - [2002]
  • Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma
    Liu H World J Gastroenterol 16 : 4410 ~ 4415 - [2010]
  • Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers
    Tangkijvanich P J Gastroenterol Hepatol 25 : 129 ~ 137 - [2010]
  • Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
    Lok AS Gastroenterology 138 : 493 ~ 502 - [2010]
  • Current strategy for staging and treatment: the BCLC update and future prospects
    Forner A Semin Liver Dis 30 : 61 ~ 74 - [2010]
  • Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma:biological significance and temporospatial distribution
    Hsu HC Cancer Res 57 : 5179 ~ 5184 - [1997]
  • Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes
    Kasahara A Dig Dis Sci 38 : 2170 ~ 2176 - [1993]